Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Clinical trial NCT00031837 · TERMINATED
Trial details
- NCT number
- NCT00031837
- Sponsor
- Gary Morrow
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2006-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.